MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202511023355 A) filed by Council Of Scientific And Industrial Research, An Indian on March 13, 2025, for Synthesis Of Anti-Coagulant Apixaban Enabled By Continuous-Flow Platform For On Demand Production.
Inventors include Ajay Kumar Singh; Ruchi Chauhan; and Abhilash Rana.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention relates to the continuous flow synthesis of anti-coagulant apixaban also; the present invention relates to a continuous flow platform with Bayesian optimization (BO) assisted reaction optimization that can autonomously explore the optimal conditions for reaction for the synthesis of formula 1.
Disclaimer: Curated by HT Syndication.